NCT04847297

Brief Summary

The first alarming symptom of a malignancy of the pancreas or periampullary tumor can be obstructive jaundice (OJ). Pancreato-duodenectomy (PD) combined with oncological treatment can provide long disease-free survival in resectable cases. The literature regarding the preoperative biliary drainage is controversial. The aim of this multicenter, prospective observational cohort study is to investigate the role of preoperative drainage, and to compare it with surgery alone.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
353

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Sep 2021

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Sep 2021Dec 2026

First Submitted

Initial submission to the registry

December 20, 2020

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 19, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

April 19, 2021

Status Verified

April 1, 2021

Enrollment Period

4.3 years

First QC Date

December 20, 2020

Last Update Submit

April 14, 2021

Conditions

Keywords

pancreatic cancerbiliary drainagepancreato-duodenectomy

Outcome Measures

Primary Outcomes (2)

  • rate of serious complications

    rate of serious complications after preoperative biliary drainage and surgery 1. Pancreatitis 2. New onset of cholecystitis 3. Cholangitis 4. Perforation 5. Hemorrhage after endoscopic retrograde cholangiopancreatography (ERCP) 6. Related to stent 1. Occlusion 2. Need for exchange Related to surgery 7. Pancreas anastomosis leakage

    120 days

  • rate of serious complications

    rate of serious complications after preoperative biliary drainage and surgery defined as: 1. Pancreatitis 2. New onset of cholecystitis 3. Cholangitis 4. Perforation 5. Hemorrhage after endoscopic retrograde cholangiopancreatography (ERCP) 6. Related to stent 1. Occlusion 2. Need for exchange Related to surgery 7. Pancreas anastomosis leakage

    120 days

Secondary Outcomes (3)

  • Length of hospitalization

    120 days

  • Mortality

    30 days

  • Mortality

    120 days

Study Arms (2)

Preoperative biliary drainage and pancreatoduodenectomy

Patients receiving preoperative biliary drainage before the removal of the tumor.

Procedure: Preoperative drainage and pancreatoduodenectomy

Pancreatoduodenectomy only

Patients undergoing only surgical intervention, without preoperative drainage.

Procedure: Pancreatoduodenectomy

Interventions

Preoperative biliary drainage before surgical removal of the tumor

Preoperative biliary drainage and pancreatoduodenectomy

Pancreatic tumor resection without previous preoperative biliary drainage

Pancreatoduodenectomy only

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will be patients diagnosed with malignant biliary obstruction who meet all the inclusion criteria but no exclusion criteria. All patients admitted with malignant biliary obstruction with- or without biliary intervention prior to the surgery in the participating hospitals will be assessed for eligibility

You may qualify if:

  • Patients ≥ 18 years
  • OJ of malignant origin (pancreatic head or periampullary tumor)
  • Total bilirubin level ≥ 40 μmol per liter
  • Signed written informed consent

You may not qualify if:

  • Proved metastasis
  • Irresectable tumor
  • Neo-adjuvant chemotherapy
  • Co-existing malignancy
  • Pregnancy
  • Patients not fit for resection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (34)

  • Abdeldayem H, Ghoneim E, Refaei AA, Abou-Gabal A. Obstructive jaundice promotes intestinal-barrier dysfunction and bacterial translocation: experimental study. Hepatol Int. 2007 Dec;1(4):444-8. doi: 10.1007/s12072-007-9018-1. Epub 2007 Sep 20.

    PMID: 19669340BACKGROUND
  • Assimakopoulos SF, Scopa CD, Vagianos CE. Pathophysiology of increased intestinal permeability in obstructive jaundice. World J Gastroenterol. 2007 Dec 28;13(48):6458-64. doi: 10.3748/wjg.v13.i48.6458.

    PMID: 18161914BACKGROUND
  • Kuzu MA, Kale IT, Col C, Tekeli A, Tanik A, Koksoy C. Obstructive jaundice promotes bacterial translocation in humans. Hepatogastroenterology. 1999 Jul-Aug;46(28):2159-64.

    PMID: 10521960BACKGROUND
  • Ito Y, Bethea NW, Baker GL, McCuskey MK, Urbaschek R, McCuskey RS. Hepatic microcirculatory dysfunction during cholestatic liver injury in rats. Microcirculation. 2003 Oct;10(5):421-32. doi: 10.1038/sj.mn.7800208.

    PMID: 14557825BACKGROUND
  • Abraham S, Szabo A, Kaszaki J, Varga R, Eder K, Duda E, Lazar G, Tiszlavicz L, Boros M, Lazar G Jr. Kupffer cell blockade improves the endotoxin-induced microcirculatory inflammatory response in obstructive jaundice. Shock. 2008 Jul;30(1):69-74. doi: 10.1097/SHK.0b013e31815dceea.

    PMID: 18562926BACKGROUND
  • Kennedy JA, Clements WD, Kirk SJ, McCaigue MD, Campbell GR, Erwin PJ, Halliday MI, Rowlands BJ. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br J Surg. 1999 May;86(5):628-33. doi: 10.1046/j.1365-2168.1999.01114.x.

    PMID: 10361183BACKGROUND
  • Minter RM, Fan MH, Sun J, Niederbichler A, Ipaktchi K, Arbabi S, Hemmila MR, Remick DG, Wang SC, Su GL. Altered Kupffer cell function in biliary obstruction. Surgery. 2005 Aug;138(2):236-45. doi: 10.1016/j.surg.2005.04.001.

    PMID: 16153432BACKGROUND
  • Sheen-Chen SM, Chau P, Harris HW. Obstructive jaundice alters Kupffer cell function independent of bacterial translocation. J Surg Res. 1998 Dec;80(2):205-9. doi: 10.1006/jsre.1998.5467.

    PMID: 9878315BACKGROUND
  • Kloek JJ, Heger M, van der Gaag NA, Beuers U, van Gulik TM, Gouma DJ, Levi M. Effect of preoperative biliary drainage on coagulation and fibrinolysis in severe obstructive cholestasis. J Clin Gastroenterol. 2010 Oct;44(9):646-52. doi: 10.1097/MCG.0b013e3181ce5b36.

    PMID: 20142756BACKGROUND
  • N Shachiri DK, D Tonev, M Shishenkov. Hemostasiologic Changes during Hepatobiliary Surgery in Patients with Obstructive Jaundice: Pathophysiology and Clinical Considerations. The Internet Journal of Anesthesiology. 2010;28(1).

    BACKGROUND
  • Betjes MG, Bajema I. The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited. J Nephrol. 2006 Mar-Apr;19(2):229-33.

    PMID: 16736428BACKGROUND
  • Uslu A, Tasli FA, Nart A, Postaci H, Aykas A, Bati H, Coskun Y. Human kidney histopathology in acute obstructive jaundice: a prospective study. Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1458-65. doi: 10.1097/MEG.0b013e32833f71f6.

    PMID: 20881503BACKGROUND
  • Padillo J, Puente J, Gomez M, Dios F, Naranjo A, Vallejo JA, Mino G, Pera C, Sitges-Serra A. Improved cardiac function in patients with obstructive jaundice after internal biliary drainage: hemodynamic and hormonal assessment. Ann Surg. 2001 Nov;234(5):652-6. doi: 10.1097/00000658-200111000-00010.

    PMID: 11685028BACKGROUND
  • Klinkenbijl JH, Jeekel J, Schmitz PI, Rombout PA, Nix GA, Bruining HA, van Blankenstein M. Carcinoma of the pancreas and periampullary region: palliation versus cure. Br J Surg. 1993 Dec;80(12):1575-8. doi: 10.1002/bjs.1800801227.

    PMID: 7507785BACKGROUND
  • Trede M, Schwall G. The complications of pancreatectomy. Ann Surg. 1988 Jan;207(1):39-47. doi: 10.1097/00000658-198801000-00009.

    PMID: 3276272BACKGROUND
  • Kimmings AN, van Deventer SJ, Obertop H, Rauws EA, Huibregtse K, Gouma DJ. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut. 2000 May;46(5):725-31. doi: 10.1136/gut.46.5.725.

    PMID: 10764720BACKGROUND
  • van der Gaag NA, Kloek JJ, de Castro SM, Busch OR, van Gulik TM, Gouma DJ. Preoperative biliary drainage in patients with obstructive jaundice: history and current status. J Gastrointest Surg. 2009 Apr;13(4):814-20. doi: 10.1007/s11605-008-0618-4. Epub 2008 Aug 23.

    PMID: 18726134BACKGROUND
  • Hatfield AR, Tobias R, Terblanche J, Girdwood AH, Fataar S, Harries-Jones R, Kernoff L, Marks IN. Preoperative external biliary drainage in obstructive jaundice. A prospective controlled clinical trial. Lancet. 1982 Oct 23;2(8304):896-9. doi: 10.1016/s0140-6736(82)90866-2.

    PMID: 6126752BACKGROUND
  • Pitt HA, Gomes AS, Lois JF, Mann LL, Deutsch LS, Longmire WP Jr. Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg. 1985 May;201(5):545-53. doi: 10.1097/00000658-198505000-00002.

    PMID: 2986562BACKGROUND
  • Wig JD, Kumar H, Suri S, Gupta NM. Usefulness of percutaneous transhepatic biliary drainage in patients with surgical jaundice--a prospective randomised study. J Assoc Physicians India. 1999 Mar;47(3):271-4.

    PMID: 10999118BACKGROUND
  • Fang Y, Gurusamy KS, Wang Q, Davidson BR, Lin H, Xie X, Wang C. Pre-operative biliary drainage for obstructive jaundice. Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD005444. doi: 10.1002/14651858.CD005444.pub3.

    PMID: 22972086BACKGROUND
  • Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krle A-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Rev Panam Salud Publica. 2015 Dec;38(6):506-14.

    PMID: 27440100BACKGROUND
  • Hritz I, Hegyi P. Early Achievable Severity (EASY) index for simple and accurate expedite risk stratification in acute pancreatitis. J Gastrointestin Liver Dis. 2015 Jun;24(2):177-82. doi: 10.15403/jgld.2014.1121.242.easy.

    PMID: 26114177BACKGROUND
  • Parniczky A, Mosztbacher D, Zsoldos F, Toth A, Lasztity N, Hegyi P; Hungarian Pancreatic Study Group and the International Association of Pancreatology. Analysis of Pediatric Pancreatitis (APPLE Trial): Pre-Study Protocol of a Multinational Prospective Clinical Trial. Digestion. 2016;93(2):105-10. doi: 10.1159/000441353. Epub 2015 Nov 26.

    PMID: 26613586BACKGROUND
  • Zsoldos F, Parniczky A, Mosztbacher D, Toth A, Lasztity N, Hegyi P; Hungarian Pancreatic Study Group and the International Association of Pancreatology. Pain in the Early Phase of Pediatric Pancreatitis (PINEAPPLE Trial): Pre-Study Protocol of a Multinational Prospective Clinical Trial. Digestion. 2016;93(2):121-6. doi: 10.1159/000441352. Epub 2015 Dec 4.

    PMID: 26641250BACKGROUND
  • Dubravcsik Z, Madacsy L, Gyokeres T, Vincze A, Szepes Z, Hegyi P, Hritz I, Szepes A; Hungarian Pancreatic Study Group. Preventive pancreatic stents in the management of acute biliary pancreatitis (PREPAST trial): pre-study protocol for a multicenter, prospective, randomized, interventional, controlled trial. Pancreatology. 2015 Mar-Apr;15(2):115-23. doi: 10.1016/j.pan.2015.02.007. Epub 2015 Feb 25.

    PMID: 25754525BACKGROUND
  • Marta K, Szabo AN, Pecsi D, Varju P, Bajor J, Godi S, Sarlos P, Miko A, Szemes K, Papp M, Tornai T, Vincze A, Marton Z, Vincze PA, Lanko E, Szentesi A, Molnar T, Hagendorn R, Faluhelyi N, Battyani I, Kelemen D, Papp R, Miseta A, Verzar Z, Lerch MM, Neoptolemos JP, Sahin-Toth M, Petersen OH, Hegyi P; Hungarian Pancreatic Study Group. High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial. BMJ Open. 2017 Sep 14;7(9):e015874. doi: 10.1136/bmjopen-2017-015874.

    PMID: 28912191BACKGROUND
  • Dubravcsik Z, Farkas G, Hegyi P, Hritz I, Kelemen D, Lasztity N, Morvay Z, Olah A, Pap A, Parniczky A, Sahin-Toth M, Szentkereszti Z, Szmola R, Takacs T, Tiszlavicz L, Szucs A, Czako L; Magyar Hasnyalmirigy Munkacsoport, Hungarian Pancreatic Study Group. [Autoimmune pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Orv Hetil. 2015 Feb 22;156(8):292-307. doi: 10.1556/OH.2015.30061. Hungarian.

    PMID: 25662147BACKGROUND
  • Hritz I, Czako L, Dubravcsik Z, Farkas G, Kelemen D, Lasztity N, Morvay Z, Olah A, Pap A, Parniczky A, Sahin-Toth M, Szentkereszti Z, Szmola R, Szucs A, Takacs T, Tiszlavicz L, Hegyi P; Magyar Hasnyalmirigy Munkacsoport, Hungarian Pancreatic Study Group. [Acute pancreatitis. Evidence-based practice guidelines, prepared by the Hungarian Pancreatic Study Group]. Orv Hetil. 2015 Feb 15;156(7):244-61. doi: 10.1556/OH.2015.30059. Hungarian.

    PMID: 25661970BACKGROUND
  • Szmola R, Farkas G, Hegyi P, Czako L, Dubravcsik Z, Hritz I, Kelemen D, Lasztity N, Morvay Z, Olah A, Parniczky A, Rubovszky G, Sahin-Toth M, Szentkereszti Z, Szucs A, Takacs T, Tiszlavicz L, Pap A; Magyar Hasnyalmirigy Munkacsoport, Hungarian Pancreatic Study Group. [Pancreatic cancer. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Orv Hetil. 2015 Feb 22;156(8):326-39. doi: 10.1556/OH.2015.30063. Hungarian.

    PMID: 25662149BACKGROUND
  • Takacs T, Czako L, Dubravcsik Z, Farkas G, Hegyi P, Hritz I, Kelemen D, Lasztity N, Morvay Z, Olah A, Pap A, Parniczky A, Patai A, Sahin-Toth M, Szentkereszti Z, Szmola R, Tiszlavicz L, Szucs A; Magyar Hasnyalmirigy Munkacsoport. [Chronic pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Orv Hetil. 2015 Feb 15;156(7):262-88. doi: 10.1556/OH.2015.30060. Hungarian.

    PMID: 25661971BACKGROUND
  • van der Gaag NA, Rauws EA, van Eijck CH, Bruno MJ, van der Harst E, Kubben FJ, Gerritsen JJ, Greve JW, Gerhards MF, de Hingh IH, Klinkenbijl JH, Nio CY, de Castro SM, Busch OR, van Gulik TM, Bossuyt PM, Gouma DJ. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010 Jan 14;362(2):129-37. doi: 10.1056/NEJMoa0903230.

    PMID: 20071702BACKGROUND
  • Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ. A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg. 2002 Jul;236(1):17-27. doi: 10.1097/00000658-200207000-00005.

    PMID: 12131081BACKGROUND
  • Sun C, Yan G, Li Z, Tzeng CM. A meta-analysis of the effect of preoperative biliary stenting on patients with obstructive jaundice. Medicine (Baltimore). 2014 Nov;93(26):e189. doi: 10.1097/MD.0000000000000189.

    PMID: 25474436BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples (serum and plasma) from all patients will be stored in the Biobank in order to study laboratory parameters later if required (eg, the laboratory could not measure it), and in order to build up a biobank for later clinical studies to which all participants will be given informed consent. The samples will be stored at -80°C.

MeSH Terms

Conditions

Pancreatic Neoplasms

Interventions

Pancreaticoduodenectomy

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Digestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Péter Hegyi

    Insitute for Translational Medicine, University of Pécs, Medical School, Pécs, Hungary

    STUDY CHAIR
  • Ákos Szűcs

    First Surgical Department of the University of Semmelweis

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Associate Professor of the First Surgical Department of the University of Semmelweis

Study Record Dates

First Submitted

December 20, 2020

First Posted

April 19, 2021

Study Start

September 1, 2021

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

April 19, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share